
David Michael Lewinsohn MD
Critical Care Medicine
Professor, Medicine, Oregon Health and Science University School of Medicine
Join to View Full Profile
3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-494-1620
Dr. Lewinsohn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Washington School of MedicineFellowship, Critical Care Medicine, 1993 - 1997
- University of California (San Francisco)Internship, Internal Medicine, 1989 - 1990
- Stanford University School of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 1990 - Present
- OR State Medical License 1998 - 2025
- WA State Medical License 1993 - 1999
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Two distinct cytokine response clusters identified in healthcare workers with apparent resistance to infection withdespite sustained occupational exposure.Avuyonke Balfour, Nomawethu Masina, Artur T L Queiroz, Bruno B Andrade, Eduardo R Fukutani
Biorxiv. 2025-03-28 - Human Neonatal MR1T Cells Have Diverse TCR Usage, are Less Cytotoxic and are Unable to Respond to Many Common Childhood Pathogens.Dylan Kain, Wael Awad, G W McElfresh, Meghan Cansler, Gwendolyn M Swarbrick
Biorxiv. 2025-03-18 - 2 citationsPostinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report.Sara C Auld, Ajay Sheshadri, Jennifer Alexander-Brett, Yael Aschner, Amy K Barczak
Annals of the American Thoracic Society. 2024-09-01
Press Mentions
- IPC Resources and Programs Highlight Global PerspectivesMay 9th, 2022
- World TB Day: World Leaders Called Upon to End TBMarch 24th, 2021
- Despite Progress, TB Remains the Leading Global Infectious Killer: WHO ReportOctober 17th, 2019
- Join now to see all
Grant Support
- Mycobacterium avium complex pulmonary infection: immunologic and transcriptomic signatures of disease and treatment responseOREGON HEALTH & SCIENCE UNIVERSITY2024–2028
- Medical Scientist Training Program of Oregon Health & Science UniversityOREGON HEALTH & SCIENCE UNIVERSITY2021–2026
- Multidisciplinary Research Training in Pulmonary MedicineOREGON HEALTH & SCIENCE UNIVERSITY2008–2026
- Multidisciplinary Research Training in Pulmonary MedicineOREGON HEALTH & SCIENCE UNIVERSITY2008–2026
- Multidisciplinary Research Training in Pulmonary MedicineOREGON HEALTH & SCIENCE UNIVERSITY2008–2026
- T cell recognition of the MR1 presented microbial metabolomeUNIVERSITY OF CHICAGO2019–2025
- Recognition of Mtb-Infected Cells by Non-Classically Restricted CD8+ T CellsPORTLAND VA MEDICAL CENTER2010–2025
- Recognition Of Mtb-Infected Cells By CD8+ T LymphocytesNational Institute Of Allergy And Infectious Diseases2001–2012
- Human MAIT Celis In Airway Mucosal Immune Responses To Intracellular InfectionsNational Institute Of Allergy And Infectious Diseases2011
- Human T Cell Responses To Mycobacterium TuberculosisNational Center For Research Resources2004
- Rhesus Macaque Model Of TuberculosisNational Center For Research Resources2000–2001
- Human T Cell Respones To Mycobacterium TuberculosisNational Institute Of Allergy And Infectious Diseases1998–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: